|
Jul 27
|
Why Wall Street is unfazed by Medicare drug pricing threat
|
|
Jul 27
|
Could Johnson & Johnson's Troubles With Talc Lawsuits Finally Be Coming to an End?
|
|
Jul 25
|
'Never going to be the same': How Nvidia is trying to revolutionize healthcare
|
|
Jul 25
|
AC Immune wins FDA fast track for Alzheimer’s vaccine
|
|
Jul 25
|
Sandoz launches ustekinumab biosimilar in Europe
|
|
Jul 25
|
AbbVie (ABBV) Beats on Q2 Earnings & Sales, Ups '24 EPS View
|
|
Jul 25
|
AstraZeneca Posts Earnings Beat, Lifts Guidance on Strong Sales
|
|
Jul 25
|
How To Earn $100 Per Month From Johnson & Johnson Stock
|
|
Jul 24
|
Claimants Face 5pm ET Fri Deadline to Accept $8 Billion Settlement in J&J Suit, Ovarian Cancer Survivors Urge Others to Vote “Yes”
|
|
Jul 24
|
J&J forecast to dominate BiTE market
|
|
Jul 23
|
J&J drops Addex’s epilepsy treatment after flunking in Phase II
|
|
Jul 23
|
Time for Healthcare ETFs?
|
|
Jul 23
|
Covid-19 vaccines: serious adverse events explained
|
|
Jul 23
|
5 Best Dividend Stocks For Roth IRA According To Reddit
|
|
Jul 23
|
J&J Allies With Mass-Tort Specialists to Seal $8 Billion Talc Settlement
|
|
Jul 23
|
Johnson & Johnson submits sNDA for SPRAVATO to treat depression
|
|
Jul 10
|
Will Q2 Earnings Power Dow ETFs?
|
|
Jul 10
|
Energised US market opportunity for pulsed field ablation
|
|
Jul 9
|
Johnson & Johnson (JNJ): One of the Best Blue Chip Dividend Stocks Right Now According to Hedge Funds?
|
|
Jul 8
|
Long-Term Dividend Growth And Recent Hikes: Johnson & Johnson, Oshkosh, And ManpowerGroup
|